Larvol Delta - ViralClear-Closes-108-Million-Equity-Financing-for-Development-of-COVID19-BroadSpectrum-Oral-AntiViral-Candidate-Merimepodib

Vicromax (merimepodib) - BioSig Tech

http://www.globenewswire.com/news-release/2020/05/20/2036504/0/en/ViralClear-Closes-10-8-Million-Equity-Financing-for-Development-of-COVID-19-Broad-Spectrum-Oral-Anti-Viral-Candidate-Merimepodib.html

May 20, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next